Capital World Investors Acquires 32,348 Shares of Regeneron Pharmaceuticals, Inc. $REGN

robot
Abstract generation in progress

Capital World Investors increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 1.6% in the third quarter, acquiring an additional 32,348 shares, bringing their total to 1,998,366 shares valued at over $1.12 billion. The article also details recent insider sales, analyst ratings, and the company’s financial performance, including its latest earnings report where it beat analyst estimates. Regeneron also announced an increase in its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin